vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and OLAPLEX HOLDINGS, INC. (OLPX). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $105.1M, roughly 2.0× OLAPLEX HOLDINGS, INC.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -12.5%, a 15.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 4.3%). OLAPLEX HOLDINGS, INC. produced more free cash flow last quarter ($32.6M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 3.1%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
IRTC vs OLPX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $105.1M |
| Net Profit | $5.6M | $-13.1M |
| Gross Margin | 70.9% | 68.0% |
| Operating Margin | 1.1% | -4.3% |
| Net Margin | 2.7% | -12.5% |
| Revenue YoY | 27.1% | 4.3% |
| Net Profit YoY | 518.5% | -48.9% |
| EPS (diluted) | $0.18 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $105.1M | ||
| Q3 25 | $192.9M | $114.6M | ||
| Q2 25 | $186.7M | $106.3M | ||
| Q1 25 | $158.7M | $97.0M | ||
| Q4 24 | $164.3M | $100.7M | ||
| Q3 24 | $147.5M | $119.1M | ||
| Q2 24 | $148.0M | $103.9M | ||
| Q1 24 | $131.9M | $98.9M |
| Q4 25 | $5.6M | $-13.1M | ||
| Q3 25 | $-5.2M | $11.1M | ||
| Q2 25 | $-14.2M | $-7.7M | ||
| Q1 25 | $-30.7M | $465.0K | ||
| Q4 24 | $-1.3M | $-8.8M | ||
| Q3 24 | $-46.2M | $14.8M | ||
| Q2 24 | $-20.1M | $5.8M | ||
| Q1 24 | $-45.7M | $7.7M |
| Q4 25 | 70.9% | 68.0% | ||
| Q3 25 | 71.1% | 69.1% | ||
| Q2 25 | 71.2% | 71.2% | ||
| Q1 25 | 68.8% | 69.5% | ||
| Q4 24 | 70.0% | 66.3% | ||
| Q3 24 | 68.8% | 68.6% | ||
| Q2 24 | 69.9% | 69.7% | ||
| Q1 24 | 66.3% | 72.1% |
| Q4 25 | 1.1% | -4.3% | ||
| Q3 25 | -4.4% | 3.7% | ||
| Q2 25 | -10.0% | -1.1% | ||
| Q1 25 | -20.5% | 8.7% | ||
| Q4 24 | -2.5% | 3.0% | ||
| Q3 24 | -34.1% | 23.5% | ||
| Q2 24 | -15.5% | 15.7% | ||
| Q1 24 | -28.9% | 19.8% |
| Q4 25 | 2.7% | -12.5% | ||
| Q3 25 | -2.7% | 9.7% | ||
| Q2 25 | -7.6% | -7.3% | ||
| Q1 25 | -19.3% | 0.5% | ||
| Q4 24 | -0.8% | -8.7% | ||
| Q3 24 | -31.3% | 12.4% | ||
| Q2 24 | -13.6% | 5.6% | ||
| Q1 24 | -34.6% | 7.8% |
| Q4 25 | $0.18 | $-0.02 | ||
| Q3 25 | $-0.16 | $0.02 | ||
| Q2 25 | $-0.44 | $-0.01 | ||
| Q1 25 | $-0.97 | $0.00 | ||
| Q4 24 | $-0.03 | $-0.01 | ||
| Q3 24 | $-1.48 | $0.02 | ||
| Q2 24 | $-0.65 | $0.01 | ||
| Q1 24 | $-1.47 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $318.7M |
| Total DebtLower is stronger | — | $352.3M |
| Stockholders' EquityBook value | $152.7M | $879.4M |
| Total Assets | $1.0B | $1.5B |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $318.7M | ||
| Q3 25 | $565.2M | $286.4M | ||
| Q2 25 | $545.5M | $289.3M | ||
| Q1 25 | $520.6M | $580.9M | ||
| Q4 24 | $535.6M | $586.0M | ||
| Q3 24 | $522.0M | $538.8M | ||
| Q2 24 | $561.5M | $507.9M | ||
| Q1 24 | $569.1M | $507.5M |
| Q4 25 | — | $352.3M | ||
| Q3 25 | — | $352.1M | ||
| Q2 25 | — | $351.9M | ||
| Q1 25 | — | $649.1M | ||
| Q4 24 | — | $650.5M | ||
| Q3 24 | — | $651.8M | ||
| Q2 24 | — | $653.1M | ||
| Q1 24 | — | $654.4M |
| Q4 25 | $152.7M | $879.4M | ||
| Q3 25 | $121.9M | $888.7M | ||
| Q2 25 | $103.7M | $874.2M | ||
| Q1 25 | $86.7M | $878.3M | ||
| Q4 24 | $90.9M | $874.4M | ||
| Q3 24 | $71.8M | $879.7M | ||
| Q2 24 | $99.2M | $863.3M | ||
| Q1 24 | $90.3M | $855.7M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $995.2M | $1.5B | ||
| Q2 25 | $964.0M | $1.5B | ||
| Q1 25 | $926.1M | $1.8B | ||
| Q4 24 | $931.4M | $1.8B | ||
| Q3 24 | $909.7M | $1.8B | ||
| Q2 24 | $919.2M | $1.8B | ||
| Q1 24 | $909.8M | $1.8B |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.40× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $32.7M |
| Free Cash FlowOCF − Capex | $14.5M | $32.6M |
| FCF MarginFCF / Revenue | 6.9% | 31.0% |
| Capex IntensityCapex / Revenue | 5.6% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $58.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $32.7M | ||
| Q3 25 | $34.9M | $8.0M | ||
| Q2 25 | $27.7M | $20.9M | ||
| Q1 25 | $-7.9M | $-2.9M | ||
| Q4 24 | $19.2M | $49.7M | ||
| Q3 24 | $24.3M | $33.5M | ||
| Q2 24 | $11.8M | $16.2M | ||
| Q1 24 | $-52.0M | $43.7M |
| Q4 25 | $14.5M | $32.6M | ||
| Q3 25 | $20.1M | $7.9M | ||
| Q2 25 | $17.3M | $20.8M | ||
| Q1 25 | $-17.3M | $-3.0M | ||
| Q4 24 | $12.4M | $49.2M | ||
| Q3 24 | $15.5M | $33.3M | ||
| Q2 24 | $3.4M | $16.1M | ||
| Q1 24 | $-61.8M | $43.3M |
| Q4 25 | 6.9% | 31.0% | ||
| Q3 25 | 10.4% | 6.9% | ||
| Q2 25 | 9.3% | 19.6% | ||
| Q1 25 | -10.9% | -3.1% | ||
| Q4 24 | 7.5% | 48.9% | ||
| Q3 24 | 10.5% | 28.0% | ||
| Q2 24 | 2.3% | 15.5% | ||
| Q1 24 | -46.8% | 43.7% |
| Q4 25 | 5.6% | 0.1% | ||
| Q3 25 | 7.7% | 0.1% | ||
| Q2 25 | 5.6% | 0.1% | ||
| Q1 25 | 5.9% | 0.0% | ||
| Q4 24 | 4.2% | 0.4% | ||
| Q3 24 | 6.0% | 0.1% | ||
| Q2 24 | 5.7% | 0.1% | ||
| Q1 24 | 7.4% | 0.5% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.81× | ||
| Q1 24 | — | 5.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
